medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2020, Número 12

<< Anterior Siguiente >>

Ginecol Obstet Mex 2020; 88 (12)


Taponamiento intrauterino con balones hidrostáticos: revisión narrativa

Robles-Elías FJ, Meade-Treviño P, Fernández-Lara JA, Robles-Morales R

Idioma: Español
Referencias bibliográficas: 85
Paginas: 870-889
Archivo PDF: 377.72 Kb.


RESUMEN

Objetivo: Evaluar la efectividad del taponamiento intrauterino con balones hidrostáticos, de acuerdo con los desenlaces clínicos, variedades, ventajas y desventajas, así como sus indicaciones y particularidades que favorecen su aplicación.
Metodología: Revisión narrativa de artículos indizados en PubMed, Medline, SciELO y Google Academic, en idioma inglés y español publicados entre 2008 y abril de 2020, con las palabras clave (MeSH): hemorragia posparto, asociada con taponamiento uterino con balón hidrostático, balón de Bakri y atonía uterina.
Resultados: Se identificaron 10,934 artículos con la palabra clave “hemorragia posparto”, que al asociarse con “taponamiento intrauterino” disminuyó a 471; con inclusión final de 85 al reunir los requerimientos de los autores, y exclusión de 386 referencias.
Conclusiones: El taponamiento intrauterino con balones hidrostáticos, por su alta eficacia clínica, costo-beneficio favorable, facilidad de aplicación, mínimas complicaciones y escasas contraindicaciones, debe formar parte del protocolo de atención obstétrica, conservando su indicación primaria en atonía uterina resistente al tratamiento médico y a las medidas iniciales, ampliando las posibilidades en pacientes con sangrado del lecho placentario, placenta previa y casos específicos de acretismo placentario. Constituye, además, una opción terapéutica para implementarse, en tiempo más temprano, después del evento obstétrico, y en casos seleccionados de alto riesgo de hemorragia posparto con fines profilácticos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Global, regional and national age-sex specific mortality for 282 causes of death in 195 countries and territories. 1980- 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1736-88. DOI: http:// doi.org/10.1016/SO140-6736(18)32203-7

  2. Observatorio de Mortalidad Materna en México. Indicadores de mortalidad materna.http://www.omm.org.mx/ index.php/indicadores-nacionales/indicadores.

  3. Fernandez-Lara JA, Toro-Ortiz C. Tasa de hemorragia, histerectomía obstétrica y muerte materna relacionada. Ginecol Obstet Mex. 2017;85(4):247-253. https://ginecologiayobstetricia. org.mx/secciones/articulos-originalesnumero83/ tasa-de-hemorragia-histerectomia-obstetrica-y-muertematerna- relacionada/

  4. Trejo-Romero JC, Reyes-Hernández MU, et al. Sutura compresiva invaginante para control de la hemorragia obstétrica. Ginecol Obstet Mex 2017;85(8):498-503. https://ginecologiayobstetricia. org.mx/secciones/editorial/sutura-compresiva- invaginante-para-control-de-la-hemorragia-obstetrica/

  5. Bateman BT, Berman MF. The Epidemiology of Postpartum Hemorrhage in a Large, Nationwide Sample of Deliveries. Anesth Analg 2018110(5):1368-1373. doi: 10.1213/ ane.0b013e3181d74898

  6. Oyelese Y, Ananth C. Postpartum Hemorrhage: Epidemiology, Risk Factors, and Causes. Clin Obstet Gynecol 2010;53(1):147-156. doi: 10.1097/grf.0b013e3181cc406d

  7. Clark S, Belfort M. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008;199(1):36.e1-36.e5. doi: 10.1016/j. ajog.2008.03.007

  8. Berg C, Harper M. Preventability of pregnancy-related deaths. Obstet Gynecol 2005;106(6):1228-1234. doi: 10.1097/01.aog.0000187894.71913.e8

  9. Rousseau A, Rozenberg P. Variation in severe postpartum hemorrhage management: A national vignette-based study. PLoS One 2018;13(12):e029074. doi: 10.1371/journal. pone.0209074

  10. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum hemorrhage. Obstet Gynecol 2017;130:e168-86. doi: 10.1097/AOG.0000000000002351.

  11. Clark SL, Hankins GDV. Obstetrics: A Text-book for the Use of Students and Practitioners. Operative Porcedures Wicho Do Not Aim At Delivery. 1st ed. Conneticut: Appleton & amp, 1997.

  12. Smith WC. Uterine tamponade with oxidized gauze in a case of total separation of the placenta with concealed hemorrhage. N Y State J Med. 1949;49(18):2187.

  13. Bakri Y, B-Lynch C. Second generation of intrauterine balloon tamponade: new perspective. BMJ Innovations 2020;6(1):1-3. doi: 10.1136/bmjinnov-2019-000404

  14. Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 2009;116(6):748- 757. doi: 10.1111/j.1471-0528.2009.02113.x .

  15. Belfort AM, Dildy GA. Intraluminal pressure in a uterine tamponade balloon is curvilinearly related to the volume of fluid infused. Am J Perinatol 2011;28(08):659-666. doi: 10.1055/s-0031-1276741

  16. Holtz RS. The control of postpartum hemorrhage by the intrauterine balloon. Am J Obstet Gynecol 1951;62(2):450- 451. doi: 10.1016/0002-9378(51)90546-7

  17. Bakri Y, Amri A. Tamponade-balloon for obstetrical bleeding. Int J Gynecol Obstet 2001;74(2):139-142. doi: 10.1016/s0020-7292(01)00395-2

  18. Georgiou C. A review of current practice in using Balloon Tamponade Technology in the management of postpartum haemorrhage. Hyperten Res Preg 2014;2(1):1-10. doi: 10.14390/jsshp.2.1

  19. De la Luna y Olsen E, Carranza-Sánchez B, et al. Experiencia con el balón de Bakri en hemorragia obstétrica. Ginecol Obstet Mex 2017;85(11):719-726. DOI: https:// doi.org/10.24245/gom.v85i11.1345

  20. Chan C, Razvi K. The use of a Sengstaken-Blakemore tube to control post-partum hemorrhage. Int J Gynecol Obstet 1997;58(2):251-252. doi: 10.1016/s0020- 7292(97)00090-8

  21. Rathore AM, Gupta S. Uterine tamponade using condom catheter balloon in the management of nontraumatic postpartum hemorrhage. J Obstet Gynaecol Res 2012;38(9):1162-1167. doi: 10.1111/j.1447- 0756.2011.01843.x

  22. Burke T, Ahn R. A postpartum haemorrhage package with condom uterine balloon tamponade: a prospective multicentre case series in Kenya, Sierra Leone, Senegal, and Nepal. BJOG 2015;123(9):1532-1540. doi: 10.1111/1471- 0528.13550

  23. Herrick T, Mvundura M. A low-cost uterine balloon tamponade for management of postpartum hemorrhage: modeling the potential impact on maternal mortality and morbidity in sub-Saharan Africa. BMC Pregnancy Childbirth 2017;17(1). doi: 10.1186/s12884-017-1564-5

  24. Makin J, Suarez-Rebling DI. Innovative Uses of Condom Uterine Balloon Tamponade for Postpartum Hemorrhage in India and Tanzania. Case Rep Obstet Gynecol 2018;2018:4952048. doi: 10.1155/2018/4952048

  25. Ramanathan A, Eckardt MJ. Safety of a condom uterine balloon tamponade (ESM-UBT) device for uncontrolled primary postpartum hemorrhage among facilities in Kenya and Sierra Leone. BMC Pregnancy Childbirth. 2018;18:168. doi.org/10.1186/s12884-018-1808-z

  26. Diemert A, Ortmeyer G. The combination of intrauterine balloon tamponade and the B-Lynch procedure for the treatment of severe postpartum hemorrhage. Am J Obstet Gynecol 2012; 206(1):65.e1–65.e4. doi: 10.1016/j. ajog.2011.07.041

  27. Mavrides E, Allard S. AJ on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. BJOG 201;124:e106-e149. https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOGMEDIA/ Women%27s%20Health/Statement%20and%20 guidelines/Clinical-Obstetrics/RCOG-Prevention-and-Management- of-Postpartum-Haemorrhage-2016.pdf?ext=.pdf

  28. Sentilhes L, Vayssière C, et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Instensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol 2016;198:12- 21. doi: 10.1016/j.ejogrb.2015.12.012

  29. Wang D, Xu S. Early usage of Bakri postpartum balloon in the management of postpartum hemorrhage: a large prospective, observational multicenter clinical study in South China. J Perinatal Med 2018;46(6):649-656. doi: 10.1515/jpm-2017-0249

  30. Wright CE, et al. Bakri ballon in the management of postpartum hemorrhage: A review. Am J Perinatol 2014;31(11):957-964. doi: 10.1055/s-0034-1372422

  31. Alkış İ, et al. The fertility sparing management of postpartum hemorrhage: A series of 47 cases of Bakri balloon tamponade. Taiwan J Obstet Gynecol 2015;54(3):232-235. doi: 10.1016/j.tjog.2014.03.009

  32. Kong CW, et al. Prognostic factors for the use of intrauterine balloon tamponade in the management of severe postpartum hemorrhage. Int J Gynecol Obstet 2018;142(1):48- 53. doi: 10.1002/ijgo.12498

  33. Brown H, Okeyo S. The Bakri tamponade balloon as an adjunct treatment for refractory postpartum hemorrhage. Int J Gynecol Obstet 2016;135(3):276-280. doi: 10.1016/j. ijgo.2016.06.021

  34. Cho HY, Park YW. Efficacy of Intrauterine Bakri Balloon Tamponade in Cesarean Section for Placenta Previa Patients. PLoS One. 2015:10(8):e0134282. doi: 10.1371/journal. pone.0134282

  35. Pillarisettya LS, Thaia T. Postpartum Hemorrhage: Use of Bakri Balloon During Cesarean Delivery, a Case Report and Review. J Clin Gynecol Obstet. 2019;8(2):57-61 doi: https:// doi.org/10.14740/jcgo556

  36. McQuivey RW, Block J. E. ebb® Complete Tamponade System: effective hemostasis for postpartum hemorrhage. Med Devices 2018:11:57-63. doi: 10.2147/MDER.S158944

  37. Uygur D, Altun-Ensari T, et al. Successful use of BT-Cath® balloon tamponade in the management of postpartum haemorrhage due to placenta previa. Eur J Obstet Gynecol Reprod Biol 2014:181:223-228. doi: 10.1016/j. ejogrb.2014.08.002

  38. Purwosunu Y, Sarkoen W. Control of Postpartum Hemorrhage Using Vacuum-Induced Uterine Tamponade. Obstet Gynecol 2016;128(1):33-36. doi: 10.1097/ aog.0000000000001473

  39. Albayrak M, Ozdemir I. Post-partum haemorrhage from the lower uterine segment secondary to placenta praevia/accreta: Successful conservative management with Foley balloon tamponade. Aust N Z J Obstet Gynaecol 2011;51(4):377- 380. doi: 10.1111/j.1479-828x.2011.01309.x

  40. Soon R, Aeby T. Cesarean scar dehiscence associated with intrauterine balloon tamponade placement after a second trimester dilation and evacuation. Hawaii Med J 2011;70(7):137-8.

  41. Ajayi O, Manjusha S. Uterine rupture complicating sequential curettage and Bakri balloon tamponade to control secondary PPH. BMJ Case Rep 2013;6. doi: 10.1136/ bcr-2012-007709.

  42. Leparco S, Viot A. Migration of Bakri balloon through an unsuspected uterine perforation during the treatment of secondary postpartum hemorrhage. Am J Obstet Gynecol 2013;208(6):e6-e7. doi: 10.1016/j.ajog.2013.02.052

  43. Suarez S, Conde-Agudelo A. Uterine Balloon Tamponade for the Treatment of Postpartum Hemorrhage: a Systematic Review and Meta-Analysis. Am J Obstet Gynecol 2020;222(4):293.e1-293.e52. doi: 10.1016/j. ajog.2019.11.1287

  44. Nagase Y, Matsuzaki S. Efficacy of Prophylactic Antibiotics in Bakri Intrauterine Balloon Placement: A Single-Center Retrospective Analysis and Literature Review. Am J Perinatol Rep 2020;10(01):e106-e112. doi: 10.1055/s-0040- 1708487

  45. Georgiou C. Intraluminal pressure readings during the establishment of a positive “tamponade test” in the management of postpartum haemorrhage. BJOG 2009;117(3):295- 303. doi: 10.1111/j.1471-0528.2009.02436.x

  46. Racusin D, Belfort M. Under Pressure: Intraluminal Filling Pressures of Postpartum Hemorrhage Tamponade Balloons. Am J Perinatol Rep 2017;(02):e86-e92. doi: 10.1055/s-0037-1602657

  47. Einerson B, Schneider P. Is There an Association Between Indication for Intrauterine Balloon Tamponade and Balloon Failure? Am J Perinatol 2017;34(02):164-168. doi: 10.1055/s-0036-1585084 .

  48. Kondoh E, Chigusa Y. Novel intrauterine balloon tamponade systems for postpartum hemorrhage. Acta Obstet Gynecol Scand 2019;00:1-6. doi: 10.1111/aogs.13692

  49. Ogoyama M, Takahashi H. Hemostatic effect of intrauterine balloon for postpartum hemorrhage with special reference to concomitant use of “holding the cervix” procedure (Matsubara). Eur J Obstet Gynecol Reprod Biol 2017;210:281- 285. doi: 10.1016/j.ejogrb.2017.01.012

  50. Kong C, To W. Intraluminal pressure of uterine balloon tamponade in the management of severe post-partum hemorrhage. J Obstet Gynaecol Res 2018;44(5):914-921. doi: 10.1111/jog.13596

  51. Revert M, Cottenet J. Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study. BJOG 2016;124(8):1255-1262. doi: 10.1111/1471-0528.14382

  52. Olsen R, Reisner D. Bakri balloon effectiveness for postpartum hemorrhage: a “real world experience.” J Matern Fetal Neonatal Med 2013;26(17):1720-1723. doi: 10.3109/14767058.2013.796354

  53. Tindell K, Garfinkel R. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG 2012;120(1):5-14. DOI: 10.1111/j.1471-0528.2012.03454.x

  54. Burke TF, Danso-Bamfo S. Shock progression and survival after use of a condom uterine balloon tamponade package in women with uncontrolled postpartum hemorrhage. Int J Gynecol Obstet 2017;139(1):34-38. doi:10.1002/ijgo.12251

  55. Sandoval García-Travesí F, Hinojosa-Cruz J. Tratamiento de la hemorragia posparto con condón hidrostático intrauterino. Ginecol Obstet Mex 2016;84(4):243-251. https:// ginecologiayobstetricia.org.mx/secciones/articulos-originales- numero83/tratamiento-la-hemorragia-pospartocondon- hidrostatico-intrauterino/

  56. Cruz-Cruz D, Peña-Dehesa H. Tratamiento activo de la hemorragia posparto y colocación del balón de Bakri en primigestas y multigestas. Ginecol Obstet Mex 2016;84(5):279-286. https://ginecologiayobstetricia.org. mx/secciones/articulos-originales-numero83/tratamientoactivo- la-hemorragia-posparto-colocacion-del-balonbakri- pacientes-primigestas-multigestas/

  57. Reynosa-Oviedo Y, López-Vera E. Eficacia y seguridad del taponamiento uterino para control de hemorragia y disminución de histerectomía obstétrica. Cohorte histórica en Nuevo León, México. Rev Colomb Obstet Ginecol. 2015;66(3):186-94. doi.org/10.18597/ rcog.23 http://www.scielo.org.co/scielo.php?pid=S0034- 74342015000300005&script=sci_abstract&tlng=es

  58. Posadas-Nava A, Moreno-Santillán A. Control de la hemorragia obstétrica mediante ligadura selectiva de las arterias uterinas. Experiencia de siete años. Ginecol Obstet Mex. 2019;87(9):576-582. https://doi.org/10.24245/gom. v87i9.2946

  59. Doumouchtsis S, Nikolopoulos K. Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review. BJOG 2013:121(4):382-388. doi: 10.1111/1471-0528.12546

  60. Doumouchtsis S. Papageorghiou A. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstetrical & Gynecological Survey 2007;62(8):540-547. doi: 10.1097/01. ogx.0000271137.81361.93

  61. Kong C, To W. Menstrual and reproductive outcomes after use of balloon tamponade for severe postpartum hemorrhage. BMC Pregnancy Childbirth 2018;18(1):451. doi: 10.1186/s12884-018-2085-6

  62. Rossi AC, Lee R. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding. a systematic review. Obstet Gynecol 2010;115(3):637-644. doi: 10.1097/ aog.0b013e3181cfc007

  63. Michelet D, Ricbourg A. Emergency hysterectomy for life-threatening postpartum haemorrhage: Risk factors and psychological impact. Gynecol Obstet Fertil 2015;43(12):773-779. doi: 10.1016/j.gyobfe. 2015.10.010

  64. Revert M, Rozenberg P. Intrauterine Balloon Tamponade for Severe Postpartum Hemorrhage. Obstet Gynecol 2018;131(1):143-149. doi: 10.1097/ aog.0000000000002405

  65. Gauchotte E, De La Torre M. Impact of uterine balloon tamponade on the use of invasive procedures in severe postpartum hemorrhage. Acta Obstet Gynecol Scand 2017;96(7):877-882. doi: 10.1111/aogs.13130

  66. Anderson Lo, Peter St. M, et al. The impact of Bakri balloon tamponade on the rate of postpartum hysterectomy for uterine atony. J Matern Fetal Neonatal Med 2017;30(10):1163- 1166. DOI: 10.1080/14767058.2016.1208742

  67. Condous GS, et al. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol 2003;101(4):767-772. doi: 10.1016/s0029- 7844(03)00046-2

  68. Ahmed S, Esraa F. The safety and effectiveness of Bakri balloon in the management of postpartum hemorrhage: a systematic review. J Matern Fetal Neonatal Med 2019;1-8. DOI: 10.1080/14767058.2019.1605349

  69. Ferrazzani S, Iadarola R. Use of an intrauterine inflated catheter balloon in massive post-partum hemorrhage: A series of 52 cases. J Obstet Gynaecol Res 2014;40(6):1603- 1610. doi: 10.1111/jog.12404

  70. Laas E, Bui C. Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhage. American J Obstet Gynecol 2012;207(4):281.e1-281. e7. doi: 10.1016/j.ajog.2012.08.028

  71. Al-Zirqi I, Vangen S. Prevalence and risk factors of severe obstetric haemorrhage. BJOG 2008;115(10):1265- 1272. doi: 10.1111/j.1471-0528.2008.01859.x

  72. Roberts C, Ford J. Trends in adverse maternal outcomes during childbirth: a population-based study of severe maternal morbidity. BMC Pregnancy Childbirth 2009;9:7. doi: 10.1186/1471-2393-9-7

  73. Creanga AA, Berg CJ. Pregnancy-Related Mortality in the United States, 2006–2010. Obstet Gynecol 2015;125(1):5- 12. doi: 10.1097/aog.0000000000000564

  74. Zhang W-H, Alexander S. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European populationbased study: the MOMS-B survey. BJOG 2005;112(1):89- 96. doi: 10.1111/j.1471-0528.2004.00303.x

  75. World Health Organization. Department of Reproductive Health and Research. Evaluating the quality of care for severe pregnancy complications The WHO near-miss approach for maternal health. https://apps.who.int/iris/bitstream/ handle/10665/44692/9789241502221_eng.pdf;jsessioni d=851AFA04F8DCFE57BC63E1FC6F826C43?sequence=1

  76. Maswime S, Buchmann E. A systematic review of maternal near miss and mortality due to postpartum hemorrhage. Int J Gynecol Obstet 2017;137(1):1-7. doi: 10.1002/ ijgo.12096

  77. Callaghan W, Kuklina E. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol 2010;202(4):353.e1-353.e6. doi:10.1016/j. ajog.2010.01.011

  78. Joseph K, Rouleau J. Investigation of an increase in postpartum haemorrhage in Canada. BJOG 2007;114(6):751- 759. doi: 10.1111/j.1471-0528.2007.01316.x

  79. Knight M, Callaghan W. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009;9:55. https:// doi.org/10.1186/1471-2393-9-55

  80. Meade-Treviño P, Fernández-Lara J. Traje antichoque no neumático: una opción en el tratamiento de la paciente con hemorragia obstétrica. Ginecol Obstet Mex 2018;86(3):200- 207. https://doi.org/10.24245/gom.v86i3.1991

  81. Higgins N, Patel S. Postpartum hemorrhage revisited. Curr Opin Anaesthesiol 2019;32(3):278-284. doi: 10.1097/ aco.0000000000000717

  82. Zaidi A, Kohli R, et al. Early Use of Fibrinogen Replacement Therapy in Postpartum Hemorrhage—A Systematic Review. Transfus Med Rev 2020;34(2):101-107. DOI: 10.1016/j. tmrv.2019.12.002

  83. Welsh A, McLintock C. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2018; 48(1):12-16. doi: 10.1111/j.1479-828x.2007.00823.x

  84. Althabe F, Therrien M. Postpartum hemorrhage care bundles to improve adherence to guidelines: A WHO technical consultation. Int J Gynecol Obstet 2020;148:290-299. doi: 10.1002/ijgo.13028

  85. Arulkumaran S, Fuchtner C. Uterine balloon tamponade for the treatment of postpartum hemorrhage; a systemic review and meta-analysis –commentary. Am J Obstet Gynecol 2020;22(4):291-292. https.//doi.org/10.1016/j. ajog.2020.01.018




2020     |     www.medigraphic.com